Bioclinica Launches NAFLD/NASH Practice

April 19, 2019

Applied Clinical Trials

Bioclinica has announced that is has assembled a team of experts dedicated to nonalcoholic fatty liver disease and nonalcoholic steatohepatitis to help sponsors develop therapeutics using medical imaging and other biomarkers in clinical trials.

Read more about it here.


Related Content: